-
Remarkable solution
for effective tissue regeneration
by inducing cell proliferation
- The World’s first EGF product
- Identical to natural human EGF
- Remarkable healing effect on diabetic foot ulcer
-
Indications
Diabetic foot ulcer, Burn, Pressure Ulcer, Mucositis, Radiation ulcer, Broad range of acute and chronic wounds
-
Specification
rSpecification
Ref.No |
Description |
Packing Unit |
EGFS0100 |
Easyef spray 10ml/bottle |
1 EA/1 BOX |
-
Research Information
Therapeutic Effect of the Recombinant Human Epidermal Growth Factor (rhEGF) in Pressure Ulcer.
Using Recombinant Human Epidermal Growth Factor with Standard of Good Care for Diabetic Foot Ulcers in Inoperable Patients.
Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats.
Expression of tumor necrosis factor-alpha and cyclooxygenase-2 mRNA in porcine split-thickness wounds treated with epidermal growth factor by quantitative real-time PCR.
Effects of Recombinant Human Epidermal Growth Factor on the Proliferation and Radiation Survival of Human Fibroblast Cell Lines in Vitro.
Effects of Recombinant Human Epidermal Growth Factor on the Proliferation and Radiation Survival of Human Fibroblast Cell Lines in Vitro.
Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.
Cho JH, Lew DH, Kim YS, Tark KC. Treatment of Acute and Chronic Wound in Immunodeficiency Patients Using Easyef(R) (EGF)
The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model
Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta
Kim EK, Li G, Lee TJ, Hong JP. The effect of human adipose-derived stem cells on healing of ischemic wounds in a diabetic nude mouse model
The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis.
Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis.
Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis.
Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines.
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy,
The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results.
Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage.
The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds.
The Effect of Recombinant Human Epidermal Growth Factor on Cisplatin and Radiotherapy Induced Oral Mucositis in Mice.
The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer.